Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two type of diabetes namely type-1 diabetes and type-2 diabetes. During last decade there is a tremendous increase in the number of diabetic population.
The analysis shows human insulins and analogues dominated the antidiabetics market in 2017.
In 2020, the market size of Diabetes Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2020; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2019 has been considered as the base year and 2020 to 2025 as the forecast period to estimate the market size for Diabetes Drug.
This report studies the global market size of Diabetes Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diabetes Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2020, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2020.
In global market, the following companies are covered:
Eli Lilly
Novo Nordisk
Abbott
AstraZeneca
Biocon
Sunpharma
Sanofi
Novartis
Merck
Pfizer
Daiichi Sankyo
Boehringer Ingelheim
Akros Pharma
Amgen
Adocia
Peptron
Takeda
Market Segment by Product Type
Insulin
Sensitizers
SGLT-2 Inhibitors
Alpha-glucosidase Inhibitors
Secretagogues
Peptide Analogs
Others
Market Segment by Application
Hospital
Clinic
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Diabetes Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diabetes Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Diabetes Drug are as follows:
History Year: 2014-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2025